Differentiation between various types of inotropes through discovery of differences in their ability to detect isoforms of Na+/K+-ATPase

Journal of Enzyme Inhibition

Volumn 12, Issue 1, 1997, Pages 53-58

  Repke, Kurt R H ^a   Megges, Rudolf ^a   Weiland, Jürgen ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Inhibitors inotropes of various types; Isoforms differentiation; Na+ K+ ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMINOGUANIDINE; BUFALIN; DIGITALIS; INOTROPIC AGENT; OUABAIN; PROGESTERONE; RHAMNOSE;

ARTICLE; CHEMICAL STRUCTURE; COMPARATIVE STUDY; DRUG BINDING SITE; PRIORITY JOURNAL;

DIGITALIS; STROPHANTHUS GRATUS;

EID: 0031011544     PISSN: 87555093     EISSN: None     Source Type: Journal    
DOI: 10.3109/14756369709027663     Document Type: Article

References (20)

1. Packer, M. (1989). Circulation, 79, 198-204.
2. Repke, K.R.H, Schönfeld, W., Weiland, J., Megges. R. and Hache, A. (1989). In Design of Enzyme Inhibitors as Drugs (Sandler, M. and Smith, HJ., eds.), pp. 435-502, Oxford: Oxford University Press.
3. Repke, K.R.H., Weiland, J., Megges, R. and Schön, R. (1993) Progr. Med. Chem., 30, 135-202.
4. Repke, K.R.H., Sweadner, K.J., Weiland, J., Megges, R. and Schön, R. (1996). Progr. Drug Res., 47, 9-52.
5. Akera, T. (1981). In Cardiac Glycosides, Part 1: Experimental Pharmacology, Handbook of Experimental Pharmacology, Vol. 56/1 (Greeff. K., ed.). pp. 287-336. Berlin: Springer-Verlag.
6. Kroneberg, G. (1969). Naunyn-Schmiedeberg's Arch. Pharmak. Exp. Path., 263, 46-59.
7. Akera, T., Fox, A.L. and Greeff, K. (1981). In Cardiac Glycosides, Part I: Experimental Pharmacology, Handbook of Experimental Pharmacology, Vol. 56/1 (Greeff, K., ed.), pp. 459-486. Berlin: Springer-Verlag.
8. Thomas, R.E. (1996). In Burger's Medicinal Chemistry and Drug Discovery, Fifth Edition, Vol. 2. Therapeutic Agents, Chapter 28 (Wolff, M.E., ed.) . pp. 153-261. Chichester: John Wiley & Sons.
9. Repke, K.R.H., Weiland, J. and Menke, K.-H. (1991). J. Enzyme Inhib., 5, 25-32.
10. Portius, H.J. and Repke, K.R.H. (1964). Arzneim.-Forsch., 14, 1073-1077.
11. Tobin, T., Akera, T., Brody, S.L., Ku, D. and Brody, T.M. (1975). Eur. J. Pharmacol., 32, 133-145.
12. Hauth, H. (1971). Planta Med., (Suppl. 4). 40-51.
13. Brown, L., Boutagy, J. and Thomas, R. (1981). Arzneim.-Forsch., 31, 1059-1064.
14. Greene, D.A. and Lattimer, S.A. (1983). J. Clin. Invest., 72, 1058-1073.
15. Schönfeld, W., Weiland, J., Lindig, C., Masnyk, M., Kabat, M.M., Kurek, A., Wicha, J. and Repke, K.R.H. (1985). Naunyn-Schmiedeberg's Arch. Pharmacol., 329, 414-426.
16. Hough, L.B., Weinstein, H. and Green, J.P. (1980). In Receptors for Neurotransmitters and Peptide Hormones (Pepeu, G., Kuhar, M.J. and Enna, S.J., eds.), pp 183-192. New York: Raven Press.
17. Berrebi-Bertrand, I., Maixent, J.-M., Christe, G. and Lelièvre, L.G. (1990). Biochim. Biophys. Acta, 1021, 148-156.
18. O'Brien, W.J., Lingrel, J.B. and Wallick, E.T. (1994). Arch. Biochem. Biophys., 310, 32-39.
19. Blanco, G., Koster, J C., Sánchez, G and Mercer, R.W. (1995). Biochemistry. 34, 9897-9903.
20. Repke, K R.H., Weiland, J., Megges, R. and Schon, R (1996). J. Enzyme Inhib., 10, 147-157